Semaglutide and the Contraceptive Pill: What the Evidence Says

What the pharmacology tells us about semaglutide and oral medicines

GLP-1 receptor agonists, including semaglutide, slow the rate at which the stomach empties its contents into the small intestine. That mechanism is part of why they reduce appetite and post-meal blood-sugar peaks, but it also has implications for any medicine absorbed through the gut lining.

The NHS medicines information for semaglutide notes that it can affect the absorption of other oral medicines. For the Wegovy tablet specifically, this matters more than it does for the injection, because the tablet itself has to survive the gastrointestinal tract to reach the bloodstream. The MHRA's approval of oral semaglutide for weight management, granted on 11 June 2026, was the first of its kind in Europe, and the prescribing information reflects this newer evidence base.

The clinical trial programme for oral semaglutide (OASIS 4) was conducted over 64 weeks in adults with obesity or overweight. It did not specifically compare contraceptive-pill hormone levels between treatment and control groups, which means there is no direct head-to-head trial answer yet. What the pharmacokinetic data do show is that delayed gastric emptying can reduce the peak absorption of some co-administered oral medicines. Your prescriber will weigh this against your individual circumstances.

What NHS guidance says, and where semaglutide differs from tirzepatide

The distinction between semaglutide and tirzepatide is worth understanding clearly, because the contraceptive-pill guidance differs between them. NHS England's guidance on weight-management injections states that women taking tirzepatide should add a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide's dual-receptor action has a more pronounced effect on gastric motility than semaglutide does. The same source does not set out an equivalent mandatory four-week rule for the injectable form of semaglutide.

Oral semaglutide is a newer and separate consideration. Because it is taken as a tablet and because it delays gastric emptying, there is a plausible mechanism by which it could interfere with the absorption of the contraceptive pill more than the injection would. The honest position is that clinical data specific to this combination are still emerging. If you are taking or considering semaglutide tablets for weight loss, this is a conversation to have with your prescriber or GP before you start, not after.

For an in-depth look at how the injection form of Wegovy specifically relates to contraceptive pill use, the Wegovy and the contraceptive pill page covers that angle in full.

Practical steps before and during treatment

The precautionary approach most clinicians take with any GLP-1 medicine and oral contraceptives is to recommend a barrier method (typically condoms) as an additional layer of protection, at least while your body is adjusting to treatment and any new dose level. This is not a reason to avoid treatment; it is a reason to plan ahead.

A few specifics worth raising with your prescriber: whether a non-oral contraceptive (an IUD, an implant, an injection, or a patch) might suit you during the treatment period; whether timing the pill as far as practical from your semaglutide dose would help; and whether your current contraceptive method needs any review given your wider health picture.

If you're reading about semaglutide tablets for the first time, our guide to whether Wegovy affects the contraceptive pill is worth reviewing alongside the overview of oral semaglutide for weight loss, which explains how the medicine works and who it is licensed for. A prescriber, not a webpage, decides what's right for your situation, but being informed before that conversation helps.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber on the same day it's submitted. If you're approved and you order before noon, your treatment is dispatched the same working day and arrives with DPD the following morning in plain, unmarked packaging. That same clinical team is available for aftercare seven days a week, so contraceptive questions that come up after you start are not left unanswered.

Pregnancy, breastfeeding, and planning to conceive

Semaglutide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. This applies to both the injection and the tablet. The MHRA's Yellow Card scheme collects ongoing safety data for newer medicines, and semaglutide for weight management carries a Black Triangle (▼) designation, meaning it is under additional post-market monitoring, including for outcomes in pregnancy where exposure has occurred.

If you're planning a family in the near future, discuss the timing with a prescriber. Treatment would need to be paused with adequate time for the medicine to clear your system before conception is attempted. The duration of that pause is a clinical decision, not something to estimate from general reading. Questions about your specific situation can be directed to our clinical team or your GP.

For context on how these medicines are assessed and what the full eligibility picture looks like, if you are also wondering where you can buy semaglutide tablets in the UK, the weight-loss treatment overview is a useful starting point. When you're ready to take the next step, speak to our prescribers through a free consultation.